BCM
AMPE

Bluefin Capital Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Bluefin Capital Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-65
Closed -$44K – 641
2016
Q1 		$44K Sell
65
-126
-66% -$84.9K ﹤0.01% 395
2015
Q4 		$201K Buy
+191
New +$189K 0.02% 414

Other funds holding AMPE

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NFG
Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return

Bluefin Capital Management's AMPE Position: Q2 2016 in Review

Bluefin Capital Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2016, closing a stake of 65 shares — an estimated $44K sold.

Bluefin Capital Management first reported a position in AMPE in Q4 2015 and held it in 2 quarters. The position peaked at $201K in Q4 2015. 74 funds tracked by Wall St. Rank hold AMPE as of Q2 2016.

  • Bluefin Capital Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2016 after selling out during the quarter.
  • Bluefin Capital Management sold 65 Ampio Pharmaceuticals Inc. shares in Q2 2016, an estimated $44K.
  • Bluefin Capital Management first reported a position in Ampio Pharmaceuticals Inc. in Q4 2015 and held it in 2 quarters.
  • Bluefin Capital Management's Ampio Pharmaceuticals Inc. position peaked at $201K in Q4 2015.
  • 74 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2016.

Based on Bluefin Capital Management's 13F filing for Q2 2016, filed 16 Aug 2016.